Co-Diagnostics, Inc.
CODXCIK 0001692415
Revenue (TTM)
$504.52K
−84.1% YoY
Q1 May 2026
Net Income (TTM)
−$30.29M
−24.6% YoY
Q1 May 2026
EPS Diluted (TTM)
−$11.50
+5.3% YoY
Q1 May 2026
Gross Margin
45.7%
Q1 May 2026
Operating Margin
-6,507.6%
Q1 May 2026
Net Margin
-6,003.8%
Q1 May 2026
Free Cash Flow (TTM)
−$31.82M
Q1 May 2026
Cash
$8.23M
Q1 May 2026
Total Debt
$3.82M
Q1 May 2026
Shares Outstanding
3.6M sh
Q1 May 2026